SCHEMBL4113168

SCHEMBL4113168

COc1cc2c(cc1O)CN(C(=O)C#Cc1cccc(Cl)c1)CC2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 5/20 0.51
DRD2 P14416 4/20 0.51
DRD4 P21917 4/20 0.51
TMEM97 Q5BJF2 1/20 0.51
PDE4B Q07343 1/20 0.49
ABCB1 P08183 1/20 0.47
DHCR7 Q9UBM7 1/20 0.46
POLB P06746 1/20 0.46
GAA P10253 1/20 0.46
DRD1 P21728 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
KMT2A Q03164 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALOX15 P16050 1/20 0.44
HSD17B10 Q99714 1/20 0.44
NPC1 O15118 1/20 0.44
THRB P10828 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4112911 1.00 DRD3 (0.51) DRD3DRD2DRD4TMEM97PDE4B
SCHEMBL4117529 0.94 PDE4B (0.55) PDE4BABCB1POLBGAAMAPT
SCHEMBL4111107 0.90 ERCC1 (0.49) DRD3DRD2DRD4TMEM97PDE4B
SCHEMBL4123261 0.84 GRM5 (0.47) PDE4BKMT2ANPC1MEN1
SCHEMBL4111406 0.84 ESR1 (0.52) PDE4BDRD1KMT2ANPC1MEN1
SCHEMBL4117672 0.83 ABHD6 (0.50) PDE4BABCB1ALOX15NPC1
SCHEMBL4113280 0.83 GRM5 (0.44) DRD3DRD2PDE4BABCB1DRD1
SCHEMBL4118264 0.83 ESR2 (0.49) PDE4BKMT2ANPC1MEN1
SCHEMBL4111987 0.81 NPC1 (0.56) PDE4BPOLBGAAMAPTHPGD
SCHEMBL4115927 0.81 GRM5 (0.46) PDE4BNPSR1KMT2ANPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-03-19 US claimed
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-03-19 US disclosed
EP-1968938-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-09-17 EP disclosed
WO-2007079957-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS PCCA, PPARA, PTGES DRD3 922/4885DRD2 1224/4885DRD4 1477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.